These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7383465)

  • 41. A vaginal suppository for abortion.
    Med Lett Drugs Ther; 1977 Nov; 19(22):89-90. PubMed ID: 927327
    [No Abstract]   [Full Text] [Related]  

  • 42. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation.
    Kent DR; Goldstein AI; Milokovich D
    J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of dinoprostone gel and gemeprost suppositories for induction of abortion in the second and third trimester].
    Mink D; Heiss C; Rothbrust S; Schmidt W
    Zentralbl Gynakol; 1995; 117(5):263-8. PubMed ID: 7793169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gameprost, sulproston and dinoproston for induced abortion in the 15th-24th week of pregnancy].
    Kamali P; Hohmann M; Herrero J; Künzel W
    Zentralbl Gynakol; 1998; 120(6):293-300. PubMed ID: 9659700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prostaglandin F 2 as an oxytocic agent in the second and third trimesters].
    Larsen JF; Pedersen PH; Sorensen B
    Ugeskr Laeger; 1973 Feb; 135(7):354-8. PubMed ID: 4688525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaginal prostaglandin E2 for missed abortion and intrauterine fetal death.
    Rutland A; Ballard C
    Am J Obstet Gynecol; 1977 Jul; 128(5):503-6. PubMed ID: 879208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of labor with PGE2 vagina suppositories.
    Fuselier PG; Wittcoff H
    J La State Med Soc; 1977 Jul; 129(7):175-7. PubMed ID: 908861
    [No Abstract]   [Full Text] [Related]  

  • 50. The induction of labour with prostaglandin E2 tablets administered intravaginally.
    Dommisse J; Davey DA; Allerton G
    S Afr Med J; 1980 Sep; 58(13):518-9. PubMed ID: 7423284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A new prostaglandin E1 analog in late interruption of pregnancy, in utero deaths and very premature ruptures of the membranes. Apropos of 117 cases].
    Henrion R; Oury JF; Dumez Y; Ammous A; Vige P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(8):939-46. PubMed ID: 6543368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of prostaglandin E2 vaginal suppositories in third-trimester fetal demise.
    Martin RW; Helman NS; Martin JN; Morrison JC
    Int J Gynaecol Obstet; 1989 Jul; 29(3):269-71. PubMed ID: 2569427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
    Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
    Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protocol for management of unsuccessful pregnancy.
    Hodgson JE; Ditmanson GM
    Minn Med; 1980 Feb; 63(2):134-8. PubMed ID: 7382975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
    Lauersen NH; Wilson KH
    Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of three concentrations of intracervical prostaglandin E2 gel for cervical ripening.
    Voss DH; Cumminsky KC; Cook VD; Nethers MS; Spinnato JA; Gall SA
    J Matern Fetal Med; 1996; 5(4):186-93. PubMed ID: 8796792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin E2 in a diaphragm. A further note.
    Schulman H; Saldana L
    Prostaglandins; 1977 Apr; 13(4):751-3. PubMed ID: 854583
    [No Abstract]   [Full Text] [Related]  

  • 58. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Anesth Analg; 1983 Nov; 62(11):1046. PubMed ID: 6578694
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostaglandin secretion by adrenal tissue of human anencephalic fetuses.
    Carr BR; Mason JI; Mitchell MD
    Am J Obstet Gynecol; 1986 Feb; 154(2):373-8. PubMed ID: 3456203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.